1. All pholcodine products recalled and withdrawn in the UK

   News item 25 March 2023 Pages: 1 - 1

2. Amoxicillin-related enterocolitis

   News item 25 March 2023 Pages: 2 - 2

3. COVID-19 vaccine-related Guillain-Barre syndrome

   News item 25 March 2023 Pages: 3 - 3

4. Gapapentin-related drug dependence and withdrawal symptoms

   News item 25 March 2023 Pages: 4 - 4

5. Maternal opioid analgesic use after delivery not associated with adverse neonatal events

   Clinical study 25 March 2023 Pages: 5 - 5

6. New legislation in New Zealand on drugs that may impair driving

   News item 25 March 2023 Pages: 6 - 6

7. Pholcodine may trigger NMBA-related anaphylaxis

   News item 25 March 2023 Pages: 7 - 7

8. Two lots of aztreonam recalled in Canada due to cracked vials

   News item 25 March 2023 Pages: 8 - 8

9. Two unauthorised children's carbocisteine syrups seized in Canada

   News item 25 March 2023 Pages: 9 - 9

10. Global Trigger Tool detects adverse drug events

    Clinical study 25 March 2023 Pages: 10 - 10

11. Rifapentine plus isoniazid: AEs and systemic drug reactions

    Clinical study 25 March 2023 Pages: 11 - 11

12. Rituximab biosimilar: no increased risk of hypersensitivity reactions

    Clinical study 25 March 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 25 March 2023 Pages: 13 - 13

14. Abemaciclib/letrozole

    Case report 25 March 2023 Pages: 14 - 14

15. Acalabrutinib

    Case report 25 March 2023 Pages: 15 - 15

16. Acalabrutinib/ibrutinib

    Case report 25 March 2023 Pages: 16 - 16

17. Acam-2000

    Case report 25 March 2023 Pages: 17 - 17

18. Acetazolamide

    Case report 25 March 2023 Pages: 18 - 18

19. Aciclovir/meropenem/vancomycin

    Case report 25 March 2023 Pages: 19 - 19

20. Ad26.cov2-s

    Case report 25 March 2023 Pages: 20 - 20

21. Adenosine/amiodarone/metoprolol

    Case report 25 March 2023 Pages: 21 - 21

22. Adenosine/diltiazem

    Case report 25 March 2023 Pages: 22 - 22

23. Adenosine/mycophenolate/tacrolimus

    Case report 25 March 2023 Pages: 23 - 23

24. Agalsidase-β

    Case report 25 March 2023 Pages: 24 - 24

25. Albendazole

    Case report 25 March 2023 Pages: 25 - 25

26. Albumin-human/everolimus/oprelvekin

    Case report 25 March 2023 Pages: 26 - 26

27. Alcohol

    Case report 25 March 2023 Pages: 27 - 27

28. Alectinib

    Case report 25 March 2023 Pages: 28 - 28

29. Alemtuzumab/natalizumab

    Case report 25 March 2023 Pages: 29 - 29

30. Alprazolam/chlordiazepoxide/valproic-acid

    Case report 25 March 2023 Pages: 30 - 30

31. Alteplase/heparin

    Case report 25 March 2023 Pages: 31 - 31

32. Ambrisentan/tadalafil

    Case report 25 March 2023 Pages: 32 - 32

33. Amikacin/azithromycin/clarithromycin

    Case report 25 March 2023 Pages: 33 - 33

34. Amiodarone

    Case report 25 March 2023 Pages: 34 - 34

35. Amiodarone

    Case report 25 March 2023 Pages: 35 - 35

36. Amiodarone

    Case report 25 March 2023 Pages: 36 - 36

37. Amiodarone

    Case report 25 March 2023 Pages: 37 - 37

38. Amiodarone

    Case report 25 March 2023 Pages: 38 - 38

39. Amiodarone

    Case report 25 March 2023 Pages: 39 - 39

40. Amiodarone

    Case report 25 March 2023 Pages: 40 - 40

41. Amiodarone

    Case report 25 March 2023 Pages: 41 - 41

42. Amiodarone/lidocaine

    Case report 25 March 2023 Pages: 42 - 42

43. Amiodarone/lidocaine

    Case report 25 March 2023 Pages: 43 - 43

44. Amiodarone/lidocaine/unspecified electrolytes

    Case report 25 March 2023 Pages: 44 - 44

45. Amiodarone/metamfetamine/local-anaesthetics

    Case report 25 March 2023 Pages: 45 - 45

46. Amivantamab/erlotinib/patritumab-deruxtecan

    Case report 25 March 2023 Pages: 46 - 46

47. Amlodipine

    Case report 25 March 2023 Pages: 47 - 47

48. Amlodipine/carvedilol/losartan

    Case report 25 March 2023 Pages: 48 - 48

49. Amoxicillin/clavulanic-acid

    Case report 25 March 2023 Pages: 49 - 49

50. Amphetamines/cannabinoids/fentanyl abuse

    Case report 25 March 2023 Pages: 50 - 50